165 related articles for article (PubMed ID: 30980115)
1. The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI.
Rozenblum L; Mokrane FZ; Yeh R; Sinigaglia M; Besson F; Seban RD; Chougnet CN; Revel-Mouroz P; Zhao B; Otal P; Schwartz LH; Dercle L
Abdom Radiol (NY); 2019 Jul; 44(7):2474-2493. PubMed ID: 30980115
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
3. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
[TBL] [Abstract][Full Text] [Related]
4. Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach.
Rozenblum L; Mokrane FZ; Yeh R; Sinigaglia M; Besson FL; Seban RD; Zadro C; Dierickx L; Chougnet CN; Partouche E; Revel-Mouroz P; Zhao B; Otal P; Schwartz LH; Dercle L
Eur J Radiol; 2020 Jan; 122():108743. PubMed ID: 31783345
[TBL] [Abstract][Full Text] [Related]
5. Imaging of neuroendocrine tumors of the pancreas.
Dromain C; Déandréis D; Scoazec JY; Goere D; Ducreux M; Baudin E; Tselikas L
Diagn Interv Imaging; 2016 Dec; 97(12):1241-1257. PubMed ID: 27876341
[TBL] [Abstract][Full Text] [Related]
6. State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging.
Carollo A; Papi S; Grana CM; Mansi L; Chinol M
Curr Radiopharm; 2019; 12(2):107-125. PubMed ID: 30843499
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
[TBL] [Abstract][Full Text] [Related]
8. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
9. The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (
Lung MS; Hicks RJ; Pavlakis N; Link E; Jefford M; Thomson B; Wyld DK; Liauw W; Akhurst T; Kuru N; Michael M
Asia Pac J Clin Oncol; 2020 Jun; 16(3):150-157. PubMed ID: 32030887
[TBL] [Abstract][Full Text] [Related]
10. Role of positron emission tomography in thyroid and neuroendocrine tumors.
Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A
Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122
[TBL] [Abstract][Full Text] [Related]
11. Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (
Matsumoto T; Okabe H; Yamashita YI; Yusa T; Itoyama R; Nakao Y; Yamao T; Umzaki N; Tsukamoto M; Kitano Y; Miyata T; Arima K; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
Surg Today; 2019 Jan; 49(1):21-26. PubMed ID: 30128759
[TBL] [Abstract][Full Text] [Related]
12. The Role of PET/CT in the Imaging of Pancreatic Neoplasms.
Duan H; Baratto L; Iagaru A
Semin Ultrasound CT MR; 2019 Dec; 40(6):500-508. PubMed ID: 31806148
[TBL] [Abstract][Full Text] [Related]
13. Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
Virgolini I; Gabriel M; Kroiss A; von Guggenberg E; Prommegger R; Warwitz B; Nilica B; Roig LG; Rodrigues M; Uprimny C
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2072-83. PubMed ID: 27174220
[TBL] [Abstract][Full Text] [Related]
14. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter N
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):310-8. PubMed ID: 25265251
[TBL] [Abstract][Full Text] [Related]
15.
Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
[TBL] [Abstract][Full Text] [Related]
16. Preoperative imaging and pathologic classification for pancreatic neuroendocrine tumors.
Deguelte S; de Mestier L; Hentic O; Cros J; Lebtahi R; Hammel P; Kianmanesh R
J Visc Surg; 2018 Apr; 155(2):117-125. PubMed ID: 29397338
[TBL] [Abstract][Full Text] [Related]
17. Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT.
Kaemmerer D; Khatib-Chahidi K; Paul Baum R; Hörsch D; Presselt N; Sänger J; Kunze A; Hommann M
Cancer Imaging; 2011 Nov; 11(1):179-83. PubMed ID: 22123527
[TBL] [Abstract][Full Text] [Related]
18. MR Imaging of Pancreatic Neuroendocrine Tumors.
Lo GC; Kambadakone A
Magn Reson Imaging Clin N Am; 2018 Aug; 26(3):391-403. PubMed ID: 30376977
[TBL] [Abstract][Full Text] [Related]
19. Radioguided surgery in patient with pancreatic neuroendocrine tumour followed by PET/CT scan as a new approach of complete resection evaluation--case report.
Kunikowska J; Słodkowski M; Koperski Ł; Kolasa A; Maryański J; Pawliszak P; Matyskiel R; Chojnowski M; Najdzik M; Królicki L
Nucl Med Rev Cent East Eur; 2014; 17(2):110-4. PubMed ID: 25088113
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors.
Tomimaru Y; Eguchi H; Tatsumi M; Kim T; Hama N; Wada H; Kawamoto K; Kobayashi S; Morii E; Mori M; Doki Y; Nagano H
Surgery; 2015 Feb; 157(2):269-76. PubMed ID: 25311263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
